Gainers on news: Hansen Medical (HNSN +21.10%) Announced an expanded agreement with Intuitive Surgical (ISRG) Arrowhead Research (ARWR +17.00%) Presented data showing 99% target gene knockdown in monkeys without toxicity using subcutaneous formulation of dynamic polyconjugate siRNA delivery system Peregrine Pharmaceuticals (PPHM +16.33%) Announced that new data support ability of phosphatidylserine-targeting antibodies to specifically target tumors and stimulate cancer-fighting immune responses; co's lead PS-targeting antibody, bavituximab, is currently being evaluated in eight clinical trials in multiple oncology indications.






